RDCM vs RDIB

RDCM exhibits exceptional financial health with a Piotroski F-Score of 8/9 and a nearly debt-free balance sheet (Debt/Equity 0.03). While the current price of $12.86 is slightly above the defensive Graham Number ($10.48), it trades at a significant discount to its growth-based intrinsic value of $20.95. The company demonstrates a powerful earnings track record with consistent beats over 25 quarters and strong YoY earnings growth of 50.90%. Despite a bearish technical trend, the fundamental valuation and profitability metrics suggest a strong undervalued growth opportunity.

RDIB exhibits severe financial distress, anchored by a critical Piotroski F-Score of 1/9 and a negative Price/Book ratio of -12.44, indicating negative shareholder equity. The company is facing a liquidity crisis with a Current Ratio of 0.17 and a Quick Ratio of 0.12, suggesting it cannot meet its short-term obligations. Revenue is in a clear decline, dropping 14.20% year-over-year, while profit margins remain negative. Combined with a 0/100 technical trend and poor insider sentiment, the data suggests a high risk of insolvency or significant capital impairment.